Strategies in regulating glioblastoma signaling pathways and anti-invasion therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31009513.
- Also identified by DOI 10.1371/journal.pone.0215547 and PMC identifier 6476530.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Glioblastoma multiforme is one of the most invasive type of glial tumors, which rapidly grows and commonly spreads into nearby brain tissue. It is a devastating brain cancer that often results in death within approximately 12 to 15 months after diagnosis. In this work, optimal control theory was applied to regulate intracellular signaling pathways of miR-451-AMPK-mTOR-cell cycle dynamics via glucose and drug intravenous administration infusions. Glucose level is controlled to activate miR-451 in the up-stream pathway of the model. A potential drug blocking the inhibitory pathway of mTOR by AMPK complex is incorporated to explore regulation of the down-stream pathway to the cell cycle. Both miR-451 and mTOR levels are up-regulated inducing cell proliferation and reducing invasion in the neighboring tissues. Concomitant and alternating glucose and drug infusions are explored under various circumstances to predict best clinical outcomes with least administration costs.
Medical subject headings
- AMP-Activated Protein Kinases
- Brain Neoplasms
- Glioblastoma
- MicroRNAs
- Signal Transduction
- TOR Serine-Threonine Kinases